Any current/future new fundraising through debt or equity?

The company recently completed a preferential fundraise of around ₹168 crore. The raised funds will primarily be used for debt reduction and potential acquisitions. No immediate acquisition target has been identified; acquisitions will be pursued thoughtfully as opportunities arise. Debt reduction is a priority, with expectations to significantly reduce net debt by about ₹150-180 crore by the end of FY '25 and achieve zero net debt by FY '26. No specific mention of plans for new fundraising through debt or equity beyond the recent preferential allotment.

Any current/future capex/capital investment/strategic investment?

The company has allocated around ₹30 crore for upgradation of infrastructure as part of its capital investment. No immediate acquisition targets have been identified, but the company is on the lookout for accretive acquisition opportunities that fit its strategic criteria. Post the preferential fund raise of ₹168 crore, the priority is debt reduction, followed by potential acquisitions when suitable opportunities arise. Any acquisition will be considered thoughtfully and methodically by the Board, with no immediate plans announced. The fund allocation primarily focuses on infrastructure upgrad

Future growth expectations in sales/revenue/volumes?

Revenue growth is expected to accelerate as inflationary pressures in the U.S. subside, boosting consumer demand. The licensed brand segment targets double-digit growth in the coming quarters, though no exact figures were provided. Growth in licensed and customer brand segments will be driven by increased penetration of lab-grown diamonds, currently at only 6%. Expansion plans include geographic growth of premium lab-grown brands from the U.S. to the UK and India. The Owned Brands segment exhibits a strong tailwind from rising acceptance of lab-grown diamonds in the U.S. market. Cost

Future growth expectations in earnings/operating earnings/profits/EPS?

Revenue growth expected to accelerate in Q3 and FY '26, driven by easing inflation and improving consumer demand. Licensed brand segment projected to grow in double digits in the coming quarters. Growth in licensed and customer brands anticipated from increased penetration of lab-grown diamonds. EBITDA margins expected to improve due to cost-cutting and capacity rationalization initiatives, with annual savings of Rs. 40-50 crore starting next quarter. Adjusted EBITDA margin improved to 10.3% in Q2, with optimism for continued margin expansion. Adjusted profit after tax rose 50% in Q2

Renaiss. GlobalQ2 FY25Consumer Durables

Renaiss. Global Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹162P/E: 16.5Market Cap: ₹1.8K CrSector: Consumer Durables

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Revenue growth is expected to accelerate as inflationary pressures in the U.S. subside, boosting consumer demand.
The licensed brand segment targets double-digit growth in the coming quarters, though no exact figures were provided.
Growth in licensed and customer brand segments will be driven by increased penetration of lab-grown diamonds, currently at only 6%.
Expansion plans include geographic growth of premium lab-grown brands from the U.S. to the UK and India.
The Owned Brands segment exhibits a strong tailwind from rising acceptance of lab-grown diamonds in the U.S. market.
Cost optimization and capacity rationalization measures are expected to improve margins and profitability, supporting sustainable growth.
Overall, management is positive about a return to growth across all segments through FY '26 with strong revenue and margin expansion.

Margin guidance

Category 3

Revenue growth expected to accelerate in Q3 and FY '26, driven by easing inflation and improving consumer demand.
Licensed brand segment projected to grow in double digits in the coming quarters.
Growth in licensed and customer brands anticipated from increased penetration of lab-grown diamonds.
EBITDA margins expected to improve due to cost-cutting and capacity rationalization initiatives, with annual savings of Rs. 40-50 crore starting next quarter.
Adjusted EBITDA margin improved to 10.3% in Q2, with optimism for continued margin expansion.
Adjusted profit after tax rose 50% in Q2 FY25; strong bottom-line growth expected in FY '26 due to revenue acceleration and cost efficiency.
Overall outlook remains positive with strong brand positioning, geographic expansion, and focus on premium/lab-grown segments driving earnings growth.

See what Renaiss. Global management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company recently completed a preferential fundraise of around ₹168 crore.
The raised funds will primarily be used for debt reduction and potential acquisitions.
No immediate acquisition target has been identified; acquisitions will be pursued thoughtfully as opportunities arise.
Debt reduction is a priority, with expectations to significantly reduce net debt by about ₹150-180 crore by the end of FY '25 and achieve zero net debt by FY '26.
No specific mention of plans for new fundraising through debt or equity beyond the recent preferential allotment.

Order book

The transcript provided does not explicitly mention current or expected orderbook or pending orders details. However, relevant insights related to business growth and demand trends include: - Licensed Brand business maintained stable revenues of Rs. 57 crore in Q2 FY25, supported by a healthy flow of orders from retail partners and the Direct-to-Consumer segment. - The Enchanted Star collection with lab-grown diamonds was recently tested with a major retail partner in the U.S., showing strong initial success. - Revenue growth is accelerating in the Licensed Brand segment with expectations of double-digit growth in coming quarters. - Consumer demand is improving post-inflationary pressures in the U.S., which may positively impact future order flows. - Geographic expansions planned in premium lab-grown segments (U.S., UK, India) could contribute to orderbook growth. No direct quantitative orderbook or pending order numbers were disclosed.

See what Renaiss. Global management said on order book — free account, 30 seconds.

Capex plans

Yes

The company has allocated around ₹30 crore for upgradation of infrastructure as part of its capital investment.
No immediate acquisition targets have been identified, but the company is on the lookout for accretive acquisition opportunities that fit its strategic criteria.
Post the preferential fund raise of ₹168 crore, the priority is debt reduction, followed by potential acquisitions when suitable opportunities arise.
Any acquisition will be considered thoughtfully and methodically by the Board, with no immediate plans announced.
The fund allocation primarily focuses on infrastructure upgrade and debt reduction, with acquisitions contingent on future opportunities.

Track Renaiss. Global — get its next earnings analysis in your feed

How does Renaiss. Global rank vs peers in Consumer Durables?

Pro feature

ThisRenaiss. Global

Rev 3Mar 3

See where Renaiss. Global sits in Consumer DurablesSee which companies these are, and every other name in the sector.Open rankings

How does Renaiss. Global rank in Consumer Durables?

Compare Renaiss. Global against every Consumer Durables company (Q2 FY25) on revenue, margins and earnings-call signals.

View Consumer Durables leaderboard →

What Renaiss. Global's management said in earlier quarters

Others in Consumer Durables this season

Khadim India Ltd (Q1 FY27)
Revenue from Operations for Q1 FY27 stood at ₹778.4 Mn, down by -18.7% YoY (Page 17, 15). Key investor presentation takeaways from Khadim India Ltd's Q1 FY27 in
Duroply Industries Ltd (Q1 FY27)
Year-on-year (YoY) revenue growth: 6.49% (Q1 FY27 vs Q1 FY26) . Key investor presentation takeaways from Duroply Industries Ltd's Q1 FY27 investor presentation
Deepa Jewellers Ltd (Q1 FY27)
Q1-FY27 Revenue from Operations: INR 4,311 Mn, up 39.0% YoY from INR 3,101 Mn in Q1-FY26 (Page 13, 11) . Key investor presentation takeaways from Deepa Jeweller
Priority Jewels Ltd (Q1 FY27)
Revenue from Operations for 3 months ended June 30, 2026 (3M27): ₹1,250 million (page 18). Key investor presentation takeaways from Priority Jewels Ltd's Q1 FY2

Compare:vs Titan Company Ltd vs Asian Paints vs LG Electronics

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Renaiss. Global Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Renaiss. Global rank in Consumer Durables?

Continue your research

What Renaiss. Global's management said in earlier quarters

Others in Consumer Durables this season